Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R
Jozaa Z. AlTamimi, Mona N. BinMowyna, Nora A. AlFaris, et al.
Saudi Pharmaceutical Journal (2020) Vol. 29, Iss. 1, pp. 27-42
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32
Fisetin—In Search of Better Bioavailability—From Macro to Nano Modifications: A Review
Joanna Szymczak, Judyta Cielecka‐Piontek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14158-14158
Open Access | Times Cited: 24
Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review
Gowtham Kannan, Benedict Mathews Paul, Parimelazhagan Thangaraj
Inflammopharmacology (2025)
Closed Access | Times Cited: 1
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin
Ruting Zhong, Mohamed A. Farag, Meiwan Chen, et al.
eFood (2022) Vol. 3, Iss. 1-2
Open Access | Times Cited: 35
Quercetin Inhibits Pyroptosis in Diabetic Cardiomyopathy through the Nrf2 Pathway
Wei Zhang, Jing Zhou, Pinfang Kang, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 29
Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
Huiyan Sun, Dandan Chen, Wenjing Xin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin
Abdur Rauf, Tareq Abu‐Izneid, Muhammad Imran, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 21, pp. 2075-2096
Closed Access | Times Cited: 14
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds
Ahmed R. Abdullah, Mahmoud A. Seliem, Emad Gamil Khidr, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Natural products and ferroptosis: A novel approach for heart failure management
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Phytomedicine (2025) Vol. 142, pp. 156783-156783
Closed Access
Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways
Passant E. Moustafa, Nesma M.E. Abo El- Nasr, Marwa E. Shabana, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 8077-8088
Closed Access | Times Cited: 3
Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease
Kaixuan Zhou, Zi Xue, Jiayu Song, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6221-6221
Open Access | Times Cited: 15
Esculeoside A Decreases Diabetic Cardiomyopathy in Streptozotocin-Treated Rats by Attenuating Oxidative Stress, Inflammation, Fibrosis, and Apoptosis: Impressive Role of Nrf2
Jozaa Z. AlTamimi, Nora A. AlFaris, Ghedeir M. Alshammari, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1830-1830
Open Access | Times Cited: 9
Inhibitory Effect of Fisetin on α-Glucosidase Activity: Kinetic and Molecular Docking Studies
Beiyun Shen, Xin-Chen Shang-Guan, Zhongping Yin, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5306-5306
Open Access | Times Cited: 18
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
Mabel L. Cummins, G Delmonte, Skylar Wechsler, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Association of high-sensitivity troponin T with left ventricular dysfunction in prediabetes
Okan Tanrıverdi, Lütfü Aşkın
Acta Cardiologica (2024) Vol. 79, Iss. 6, pp. 699-704
Closed Access | Times Cited: 2
The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events
Mahboobe Sattari, Jamal Amri, Mohammad Esmaeil Shahaboddin, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1753-1771
Closed Access | Times Cited: 2
Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
Raghad Khalid AL-Ishaq, Alena Mazuráková, Peter Kubatka, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6073-6073
Open Access | Times Cited: 10
Cardioprotective effects of phytopigments via multiple signaling pathways
Ressin Varghese, C. George Priya Doss, Raju Suresh Kumar, et al.
Phytomedicine (2021) Vol. 95, pp. 153859-153859
Closed Access | Times Cited: 12
Bee venom ameliorates cardiac dysfunction in diabetic hyperlipidemic rats
Faten Zahran, Alaa S. Mohamad, Nabila Zein
Experimental Biology and Medicine (2021) Vol. 246, Iss. 24, pp. 2630-2644
Open Access | Times Cited: 11
A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
Pengyu Yao, Xiaoni Yang, Yun Qiao
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity
Boyu Wang, Jiameng Wang, Changxing Liu, et al.
Journal of Applied Toxicology (2024)
Closed Access | Times Cited: 1
Topical application of Aloe gel and/or olive oil combination promotes the wound healing properties of streptozotocin-induced diabetic rats
Diaa Massoud, Maged Fouda, Moustafa Sarhan, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 39, pp. 59727-59735
Closed Access | Times Cited: 7
Cardioprotective Effect of <i>Gynostemma pentaphyllum</i> against Streptozotocin Induced Cardiac Toxicity in Rats via Alteration of AMPK/Nrf2/HO-1 Pathway
Fang Chen, Huan-Yu Zhang, Di He, et al.
Journal of Oleo Science (2022) Vol. 71, Iss. 7, pp. 991-1002
Open Access | Times Cited: 7
A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview
Shraddha Singh Raghav, Bhavna Kumar, Neeraj Kumar Sethiya, et al.
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 511-546
Open Access | Times Cited: 7
Omnifarious fruit polyphenols: an omnipotent strategy to prevent and intervene diabetes and related complication?
Yao Chen, Xuejiao Qie, Wei Quan, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 20, pp. 4288-4324
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top